patent/CN-103747787-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103747787-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d12fcf94a35348198bf31558dcff2cf6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6115b7f4561db088f26a575e9339fed0
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-16
filingDate	2012-05-25^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a749e4a617cca0408c3c909a6139763e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f65cd0ce56250dbe97cec5f5140fca7a
publicationDate	2014-04-23^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-103747787-A
titleOfInvention	Substituted 2-benzylidene-2H-benzo[b][1,4]thiazin-3(4H)-ones, their derivatives and their therapeutic use
abstract	The present invention relates to compounds of formula I: and salts thereof, wherein R 1 , R 2 , R 3 , R 4 , Ar and n are as defined herein. Processes for the preparation of compounds of formula I are also provided. The present invention also includes methods of using the compounds of formula I to treat cell proliferative diseases such as cancer.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105777592-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104892546-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105777592-B
priorityDate	2011-05-27^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010077680-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9937641-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4078062-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6951855-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7049312-B1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466782775 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466587794

Showing number of triples: 1 to 38 of 38.